NCT06135181 - A Study to Learn More About the Safety and the Blood Level of BAY1747846 Given as Injection Into the Vein at Increasing Single Doses in Chinese Healthy Male Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 26, 2020

Primary Completion Date

February 2, 2021

Study Completion Date

April 30, 2021

Conditions

Contrast Enhancement in Magnetic Resonance ImagingHealthy Volunteers

Interventions

DRUG

Gadoquatrane (BAY1747846) 0.03 mmol Gd/kg

0.03 mmol Gd/kg by intravenous injection (at 2 mL/s)

DRUG

Gadoquatrane (BAY1747846) 0.1 mmol Gd/kg

0.1 mmol Gd/kg by intravenous injection (at 2 mL/s)

DRUG

Matching placebo

0.9% sodium chloride by intravenous injection (at 2 mL/s)

Trial Locations (1)

Beijing Hospital, Beijing